quarterly result axisbank

Q3 FY2026 Result Highlights – Axis Bank, TVS Motor, GE Vernova, Pondy Oxides, Bikaji Foods, Sagility & Thyrocare

Spread the love

Q3 FY2026 Quarterly Result Highlights of Q3 FY2026 Result Highlights – Axis Bank, TVS Motor, GE Vernova, Pondy Oxides, Bikaji Foods, Sagility & Thyrocare

Axis Bank Q3 FY2026 Result: Net Profit Rises 3.98% YoY

  • Deposit Growth: 5% QoQ and 15% YoY.
  • Advances Growth: 4% QoQ and 14% YoY.
  • Core Operating Revenue: Up 7% YoY.
  • Core Operating Profit: Up 7% YoY.
  • Profit After Tax (PAT): Up 28% QoQ.
  • CET1 Ratio: 14.5%.
  • Net Profit (PAT) ₹6,490 crore +3%
    Net Interest Income (NII) ₹14,287 crore, +5%
    Operating Profit ₹10,815 crore, +7%
    Net Interest Margin (NIM) 3.64% down from 4.06%
    Gross NPA 1.40%, Improved
  • Net profit rose 28%  QoQ, recovering from ₹5,090 crore in Q2 FY26.
  • This indicates that the earnings dip in the previous quarter was temporary rather than structural.
  • Net Interest Income and Fees
  • NII growth of 5% YoY was driven by healthy loan disbursements
  • Rising deposit costs partially offset yield expansion
  • Fee income grew 12% YoY to ₹6,100 crore
  • Retail fees contributed 71% of total fee income, improving earnings stability.
  • Stock Verdict: Positive

TVS Motor Q3 FY2026 Results – Revenue Surges 37% & Profit Jumps 53%

  • TVS Motor Posts Record Q3 Results; Revenue Surges 37%, Profit Jumps 53%
  • TVS Motor Company reported a record-breaking Q3 FY26, with sales volume up 27% YoY.
  • Operating revenue soared 37% to INR 12,476 Cr, EBITDA climbed 51% to INR 1,634 Cr, and PAT surged 53% to INR 940 Cr, improving margins by 120 bps.
  • Electric two-wheeler and three-wheeler sales saw significant growth, and the company raised FY26 capex guidance to INR 1,700 Cr for future expansion.
  • Margins: Operating EBITDA margin improved by 120 basis points to 13.1% from 11.9% YoY.
  • Sales Volume: 27% YoY growth.
  • Electric two-wheeler sales grew 40% YoY, and three-wheeler sales more than doubled, indicating success in high-growth segments.
  • TVS Credit’s PBT grew 21% YoY, supporting overall group performance.
  • Cash Flow implication: Capex guidance revised upwards to INR 1,700 crores for FY26, and total investments to INR 2,900 crores, signaling aggressive expansion plans in key areas like Norton, TVS Credit, and e-bikes.
  • Management is confident about a strong Q4 due to GST reduction and industry growth.
  • They project an 8-9% CAGR for the two-wheeler industry long-term.
  • Strategy for commodity inflation includes scale benefits, cost reduction, and selective price hikes.
  • New Norton motorcycles are slated for a 2026 launch.
  • Stock Verdict: Positive

GE Vernova T&D India Q3 FY2026 Result: 58% Revenue Jump, Order Book Up 41%

  • GE Vernova T&D India Q3 FY’26 result came withe revenue jumping 58% YoY to INR 17 billion.
  • Order bookings surged 41% YoY to INR 29.4 billion, expanding the backlog to INR 143.8 billion.
  • Profit before tax and exceptional items demonstrated exceptional strength, more than doubling to INR 4.6 billion from INR 1.9 billion a year prior.
  • The company’s operational efficiency is underscored by its EBITDA margin, which stood at a healthy 26.7% for the quarter. For the nine-month period of FY’26, the margin improved by 80 basis points year-on-year to 27.1%.
  • Management remains optimistic about growth drivers from India’s energy targets, grid modernization, and renewable integration, maintaining a debt-free status and planning significant capex.
  • The order book saw a substantial 41% year-on-year increase, reaching INR 29.4 billion in Q3 FY’26, bolstered by key wins like the Chandrapur HVDC refurbishment.
  • The total order backlog now stands at INR 143.8 billion as of December 2025, a 10% sequential rise, indicating a strong pipeline for future revenue. For the first nine months of FY’26, total order bookings amounted to INR 61.6 billion, with exports contributing 15%.
  • Stock Verdict: Positive

Pondy Oxides Q3 FY2026 Result: Net Profit up 149%

  • Pondy Oxides & Chemical achieved its strongest quarterly performance in Q3FY26 with net profit surging 149% to ₹376 million and revenue growing 55% to ₹776 crores.
  • The company expanded lead capacity by over 50% to 204,000 metric tons per annum and is doubling copper capacity to 12,000 metric tons, with exports contributing 67% of revenue and value-added products representing 65% of lead segment sales.
  • The company is aggressively expanding lead and copper recycling capacities, boosting exports and benefiting from regulatory tailwinds, targeting over 20% CAGR.
  • Profitability saw a significant uplift, with EBITDA climbing 96% YoY to ₹157 crore and Profit After Tax (PAT) soaring 114% YoY to ₹101 crore.
  • EBITDA margins remained robust, consistently exceeding 7% for the nine-month period and hovering around 7-8% on a quarterly basis. The lead EBITDA per ton also showed strength, rising 46% YoY to ₹18,086 for the nine months.
  • Stock Verdict: Neutral

Bikaji Foods Q3 FY2026 Results 2026: Net Profit Surged by 116.29% & Revenue Up 10.72% YoY

  • During Q3 FY26, Bikaji Foods International’s profit increased 116.29% YoY at ₹62.18 crores
  • revenue increased by 10.72% YoY at ₹790.01 crores.
  • According to the consolidated figures, Bikaji Foods International’s quarterly PAT increased by 4,719.97% YoY, while revenue increased by 23.94%.
  • Bikaji Foods International clocked Q3 FY26 standalone revenue of ₹730.68 crores vs ₹676.71 crores. 
  • On the profit front,  Bikaji Foods International earned a standalone PAT of ₹64.70 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹30.24 crore.
  • According to the standalone figures, Bikaji Foods International’s quarterly PAT increased by 113.91% YoY, while revenue increased by 7.98%.
  • Stock Verdict: Neutral

Sagility Q3 Results 2026 Highlights: Revenue Up 36% YoY & PAT 23%

  • Sagility Ltd reported strong growth in Q3 FY2026, with net profit rising 23.37% to ₹267.6 crore from ₹216.9 crore a year ago.
  • Revenue surged 35.7% to ₹1,971.1 crore from ₹1,453 crore in the same period.
  • EBITDA grew 30.4% to ₹511 crore, with margins at 25.9%, slightly down from 26.9% last year.
  • The company noted that 2026 is expected to be a consolidation phase for Medicare, with reduced participation in low-margin, high-utilisation populations.
  • Organic Growth: 19.9% year-over-year in INR (13.9% in constant currency).
  • Adjusted EBITDA: ₹5,125 million, a growth of 24.2% year-over-year, with a margin of 26%.
  • Adjusted PAT: ₹3,229 million, up 23% year-over-year.
  • Segment Performance
  • The company experienced growth in both Payer and Provider segments:
  • Payers: Reported 37.3% growth year-on-year, contributing 90.4% of the total revenue.
  • Providers: Reported 21.6% year-on-year growth, delivering 9.6% of the total revenue.
  • Sagility acquired business from 22 existing clients and added three new clients during Q3.
  • The aggregate annual contract value (ACV) won from existing and new clients stood at ₹30.5 million for Q3.
  • Key new client wins include a top 10 health insurance company, a benefit administration company, and a regional health insurance plan.
  • Stock Verdict: Neutral

Thyrocare Q3 FY2026: Profit up 37%

  • Thyrocare Technologies posted a strong performance for Q3 FY26.
  • Net profit for the period jumped 36.7% on a YoY basis to ₹26.1 Crore. In the previous corresponding period, the company posted a net profit of ₹19.1 Crore , supported by higher volumes and operating leverage.
  • Revenue from the operations jumped 19.30% on a YoY basis to ₹182 Crore  in the December 2025 quarter. In the previous quarter, the company’s revenue from operations stood at ₹152.50 Crore . 
  • The business said that its operating performance also improved sharply with EBITDA surging from ₹39.70 Crore  to ₹58.30 Crore , registering a growth of 46.70% on a YoY basis. 
  • EBITDA margin for the period witnessed improvements to 32% against 26% in the previous corresponding quarter. This reflects on better cost efficiencies and increased benefits.
  • On a sequential basis, the company reported profit before tax of ₹36.60 Crore . 
  • For the nine months ended December 2025, Thyrocare posted a net profit of ₹105.20 Crore  as compared to ₹74 Crore  in the previous corresponding period. Revenue from operations for the period jumped to ₹563.60 Crore  versus ₹459.20 Crore  in the same quarter of previous year. 
  • Diagnostic Testing Services is the largest segment. It reported a revenue of ₹182.4 Crore  in Q3, up from ₹151.9 Crore  a year ago. It posted segment profit before tax of ₹36.8 Crore , reflecting strong operating leverage.
  • Stock Verdict: Negative

Leave a Reply

Your email address will not be published. Required fields are marked *